NUJUPA Trademark

Trademark Overview

On Tuesday, October 1, 2019, a trademark application was filed for NUJUPA with the United States Patent and Trademark Office. The USPTO has given the NUJUPA trademark a serial number of 88637566. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 17, 2023. This trademark is owned by AbbVie Biotechnology Ltd. The NUJUPA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
nujupa

General Information

Serial Number88637566
Word MarkNUJUPA
Filing DateTuesday, October 1, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 21, 2020

Trademark Statements

Goods and Servicespharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 4, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbVie Biotechnology Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHamilton, Pembroke HM11
BM
Party NameAbbVie Biotechnology Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHamilton HM11
BM

Trademark Events

Event DateEvent Description
Monday, April 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 17, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, September 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 8, 2022SOU EXTENSION 5 GRANTED
Tuesday, August 30, 2022SOU EXTENSION 5 FILED
Thursday, September 8, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 30, 2022TEAS EXTENSION RECEIVED
Tuesday, March 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 11, 2022SOU EXTENSION 4 GRANTED
Friday, March 11, 2022SOU EXTENSION 4 FILED
Friday, March 11, 2022TEAS EXTENSION RECEIVED
Tuesday, September 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 17, 2021SOU EXTENSION 3 GRANTED
Friday, September 17, 2021SOU EXTENSION 3 FILED
Friday, September 17, 2021TEAS EXTENSION RECEIVED
Wednesday, March 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 8, 2021SOU EXTENSION 2 GRANTED
Monday, March 8, 2021SOU EXTENSION 2 FILED
Monday, March 8, 2021TEAS EXTENSION RECEIVED
Friday, September 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 16, 2020SOU EXTENSION 1 GRANTED
Wednesday, September 16, 2020SOU EXTENSION 1 FILED
Wednesday, September 16, 2020TEAS EXTENSION RECEIVED
Tuesday, March 17, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 16, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 13, 2019ASSIGNED TO EXAMINER
Friday, October 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 4, 2019NEW APPLICATION ENTERED

Related Keywords

nujupa gastrointestinal hormonal neurological respiratory ophthalmic dermatological psychiatric diseases disorders related